Equities

Max Healthcare Institute Ltd

MAXHEALTH:NSI

Max Healthcare Institute Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)971.75
  • Today's Change-24.25 / -2.43%
  • Shares traded4.35m
  • 1 Year change+58.54%
  • Beta0.7426
Data delayed at least 15 minutes, as of Nov 25 2024 10:21 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Max Healthcare Institute Ltd had net income fall -4.16% from 11.04bn to 10.58bn despite a 18.49% increase in revenues from 45.63bn to 54.06bn. An increase in the cost of goods sold as a percentage of sales from 21.72% to 22.12% was a component in the falling net income despite rising revenues.
Gross margin79.38%
Net profit margin17.63%
Operating margin21.85%
Return on assets8.91%
Return on equity12.72%
Return on investment10.05%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Max Healthcare Institute Ltd fell by 3.94bn. However, the company earned 11.57bn from its operations for a Cash Flow Margin of 21.39%. In addition the company used 12.85bn on investing activities and also paid 2.64bn in financing cash flows.
Cash flow per share13.84
Price/Cash flow per share71.94
Book value per share90.51
Tangible book value per share33.68
More ▼

Balance sheet in INRView more

Max Healthcare Institute Ltd has a Debt to Total Capital ratio of 16.73%, a higher figure than the previous year's 7.49%.
Current ratio1.26
Quick ratio1.20
Total debt/total equity0.201
Total debt/total capital0.1673
More ▼

Growth rates in INR

Year on year, growth in dividends per share increased 50.00% while earnings per share excluding extraordinary items fell by -4.52%. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)8.59%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
6.74
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.